Form 4: Integra LifeSciences SVP Mosebrook Sells Shares
SEC Form 4 Filing
Jeffrey Mosebrook, SVP, Fin & Princ Acct Officer of Integra LifeSciences Holdings Corp, sold 1,191 shares of common stock on August 19, 2024.
Summary
- On August 19, 2024, Jeffrey Mosebrook, SVP, Fin & Princ Acct Officer of Integra LifeSciences Holdings Corp, sold 1,191 shares of common stock.
- The shares were sold at a weighted average price of $21.5792, with individual sale prices ranging from $21.575 to $21.58.
- Following the transaction, Mosebrook directly owns 36,088 shares of Integra LifeSciences common stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a stock sale by an officer. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This Form 4 filing is a routine disclosure of insider trading activity, which is common among corporate executives. It provides transparency to investors regarding the buying and selling of company stock by its officers.
Stakeholder Impact
- The sale of shares by an officer could be perceived negatively by some shareholders, but it is a relatively small transaction and may not have a significant impact.
Key Dates
| Date | Description |
|---|---|
| 08/19/2024 | Date of transaction: Jeffrey Mosebrook sold 1,191 shares of Integra LifeSciences common stock. |
| 08/20/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.